No Data
No Data
Acrux Secures AU$1.5 Million Funding Facility; Shares Fall 3%
Acrux (ASX:ACR) secured a AU$1.5 million funding facility with a monthly interest of 1.33% with Radium Capital. The short-term facility will be repaid later in 2024. It is secured against the specialt
Percheron Therapeutics Appoints CFO
Percheron Therapeutics (ASX:PER) appointed Deborah Ambrosini as its chief financial officer and company secretary, effective immediately, according to a Monday filing with the Australian bourse. Ambro
Acrux, TruPharma Launch Dapsone 5% Gel in US
Pharmaceutical company Acrux (ASX:ACR) and its partner TruPharma introduced a generic version of the topical prescription medication Dapsone 5% Gel in the US, according to a Wednesday filing with the
Acrux Gets AU$3 Million Tax Rebate for Fiscal Year 2023
Acrux (ASX:ACR) received a rebate worth AU$2.9 million for the fiscal year ended June 30 as part of the Australian government's research and development tax incentive scheme. The scheme aims to encour
US FDA Approves Review of Acrux (ASX:ACR) Nitroglycerin Ointment
Acrux Limited (ASX:ACR) Insider Purchases A$91,665.00 in Stock
Acrux Limited (ASX:ACR – Get Rating) insider Donald Brumley bought 1,455,000 shares of the business's stock in a transaction dated Thursday, March 9th. The shares were purchased at an average cost of
No Data